The ASH Subcommittee on Precision Medicine sponsors a live virtual series on Precision Hematology.  The series is designed to provide clinicians and researchers in hematology foundational information on the latest technologies available for data acquisition, discovery, diagnosis, and decision making for hematologic diseases. Please click on “Enroll” to register for an upcoming topic, or to view a recording of a past topic.

• Identification of Somatic Mutations 

• Identification of Deleterious Germline Variants

• Reporting somatic variants to health care providers

• Targeted treatment: Choose wisely and use of MRD

• How to communicate genetic results to patients and their families

• Reimbursement and Regulation

• Big data and AI in hematology research

• Proteomics in Hematology

• Functional Precision Hematology

• Pharmacogenomics in Hematology

• Single Cell Multi-omics in Precision Medicine

• Bringing AI into Clinical Diagnostics

• Common Genetics to Understand Cardiovascular Diseases

• Variant of Unknown Clinical Significance (VUS): Definition, Evaluation, and Investigation
• Non-Malignant Inflammatory Disorders: VEXAS Syndrome
• Whole Genome Sequencing/Whole Transcriptome Sequencing in Acute Lymphoid Leukemia
• Non-Malignant Inflammatory Disorders: Hemophagocytic Lymphohistiocytosis (HLH)/Cytokine Release Syndrome (CRS)